Accepting Q2 2026 Engagements · Limited to 3 active builds at a time

Board-Grade Clinical Trial Financial Architecture

We build your clinical trial financial model on the TrialCast™ platform — combining 15+ years of biotech FP&A expertise with purpose-built technology. Then we hand you the keys.

Expert-built. Platform-delivered. Your team runs scenarios from day one.

Schedule Your Intro Call
How It Works

One Engagement. Ongoing Access.

TrialCast starts with an expert-led implementation — your trial, your data, built by someone who's done this for 15 years. Then your team gets direct access to the platform for real-time scenario modeling.

Capacity Note
Every TrialCast Engagement is led directly by our founding team — not delegated. We limit active builds to maintain the quality our clients depend on. We are currently accepting Q2 2026 engagements — intro calls typically book 2–3 weeks out.
Foundational
Phase 1–2 trial · Early stage
$15,000
per trial
+ $1,500 / mo platform access
Single trial, standard complexity. Parametric cost model, enrollment curve, monthly spend distribution, and board-grade forecast outputs.
Most Common
Standard
Phase 2–3 trial · Moderate complexity
$22,000
per trial
+ $2,000 / mo platform access
Multi-site trial with CRO budget complexity. Full cost architecture with site-level modeling, regional mix, and scenario sensitivity framework.
Complex
Phase 3 / registration-enabling
$35,000
per trial
+ $2,500 / mo platform access
Late-stage, high-stakes trials with global sites, large CRO commitments, and active fundraise or board reporting requirements.
Platform access billed annually. Base pricing covers one standard trial architecture. Complex master protocols or adaptive designs scoped individually.

Additional Trials

Pricing reflects the reduced architecture time for clients already on the platform.

ADDITIONAL TRIAL BUILD
Starting at $10,000 per trial
ADDITIONAL SCENARIOS ACCESS
Starting at $1,500/mo per trial
Pricing scales based on trial complexity, phase, and portfolio size. All engagements begin with an intro call.
Who We Work With
A Deliberate Practice

We work with a select number of companies at a time.

Every TrialCast Engagement is led directly by our founding team — not delegated to a junior analyst, not templated from a prior engagement. That means we have a hard limit on how many we take on, and we choose carefully.

"We're not looking for volume. We're looking for companies where the financial architecture genuinely matters — where the board is asking hard questions, where a capital raise is on the horizon, and where the CFO needs something defensible, not just something that looks like a model."
15+ years
Biotech FP&A domain expertise
$100M+
In capital raises directly supported
Phase I → BLA
Full development lifecycle coverage
All major TAs
Oncology, rare disease, gene therapy & more
THE PROCESS

From Protocol to Platform in Four Steps

A focused engagement designed to minimize your team's time and maximize the quality of your financial architecture.

01

Intro Call

A 20-minute conversation to understand your trial, your timeline, and what's driving the need. We evaluate fit as much as you do — come with questions.

02

Data Intake

We send a structured data request — schedule of assessments, enrollment parameters, site budgets, regional scope. Designed to minimize your team's time.

03

Architecture Build

Your protocol data is translated into a living financial architecture — cost structures, enrollment curves, scenario frameworks, and board-grade outputs.

04

Walkthrough & Handoff

We walk your team through the architecture, validate assumptions together, and activate your Scenarios access so you can model changes from day one.

Designed For

Built for the Clinical Executive Team

CFOs & Finance VP

Stop guessing when capital will be needed. Defend your burn rate to the board with P50/P90 statistical modeling grounded in AACT data rather than simple straight-line assumptions.

Clinical Operations VP

Instantly see the financial impact of protocol amendments. Negotiate CRO change orders armed with independent, bench-marked cost data for every aspect of the trial.

Heads of FP&A

Offload the technical debt of maintaining a 50-tab clinical Excel model. Get a dynamic, continually updated architecture that exports directly to your corporate financial model.

WHO'S BEHIND THIS

Biotech Finance Expertise, Encoded in Software

TrialCast is built and delivered by the team behind Caladan.ai — biotech finance insiders who built the platform because we lived the problem.

Every engagement is led by a biotech FP&A expert with 15+ years of hands-on experience across oncology, rare disease, gene therapy, immunology, and neuroscience — spanning Phase I through commercial launch. Models built on this expertise have been the direct basis for over $100 million in capital raises.

The TrialCast platform encodes that pattern recognition into infrastructure — so your financial architecture isn't trapped in a spreadsheet or dependent on a single person's availability.

All Major Therapeutic Areas Oncology, rare disease, gene therapy, immunology, neuroscience, and more
Phase I through Commercial Launch Full development lifecycle from first-in-human to post-market
$100M+ in Capital Raises Supported Financial models that have directly underpinned fundraising and board decisions
Powered by TrialCast™ The same platform used to manage active clinical trial portfolios

Your Trial Budget Deserves Architecture, Not Guesswork

Book a 20-minute intro call. We'll discuss your portfolio, scope the engagement, and determine the right fit.

Book Your Intro Call

No commitment required. 20 minutes to see if this is a fit.